|
Real-time Estimate
Cboe BZX
01:08:55 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 8.565 USD | -2.89% |
|
-2.39% | -18.29% |
| 25/08 | Immatics Announces $150 Million Underwritten Offering | MT |
| 18/08 | Immatics' Q2 Net Loss Narrows as Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMATICS N.V. | Bio Therapeutic Drugs | -2.72% | -2.39% | -18.29% | +29.80% | -36.96% | 120.56Cr |  |  | |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
